The data of this study showed that the levels of CRP, IL-6, and TNF-α in the observation group after treatment were significantly lower than those before treatment, indicating that atorvastatin could help to control the inflammatory reaction of DN patients. The gene discussed is CRP; the disease is liver dysplastic nodule.